LEO Pharma
Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
July 21, 2025Medical Communications, Mergers and Acquisitions, Research and Development Boehringer Ingelheim, Dermatology, LEO Pharma, Spevigo, generalised pustular psoriasis, partnership, skin disease
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a treatment for generalised pustular psoriasis …
LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
July 7, 2025Manufacturing and Production Dermatology, Helle Hedegaard Juhl, LEO Pharma, Skin, dermatology
Danish dermatology company, LEO Pharma, announced the appointment of new executive vice president (EVP) of global people and corporate affairs, …
LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition
June 3, 2025Research and Development Dermatology, LEO Pharma, Skin, clinical trial, delgocitinib cream, rare skin condition
LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe palmoplantar pustulosis (PPP). The DELTA …
MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain
December 16, 2024LEO Pharma, eczema
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …
LEO Pharma to acquire Timber Pharmaceuticals for up to $36m
August 22, 2023Business Services Dermatology, LEO Pharma, Timber Pharmaceuticals, acquisition
Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by LEO Pharma, with a total …
LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland
June 19, 2023LEO Pharma, appointment, general manager, vice president
Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice …
LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema
November 2, 2020Research and Development, Sales and Marketing LEO Pharma, eczema, pharma
LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
Leo Pharma gets EU scientific approval for its psoriasis drug Enstilar
March 21, 2016Business Services, Research and Development, Sales and Marketing EU, Enstilar, LEO Pharma, psoriasis vulgaris
Leo Pharma on Monday said its drug to treat inflammatory skin condition has received scientific approval in the European Union. …
LEO Pharma buys dermatology portfolio from Astellas
November 12, 2015Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers
LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …
Boehringer launches new transparency regime
May 12, 2014Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency
Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …
LEO Pharma to release clinical trial data
October 24, 2013Research and Development, Sales and Marketing Goldacre, LEO Pharma, all trials, transparency
LEO Pharma has announced that it will start releasing clinical trial data from studies dating back to almost 25 years …
Leo exaggerates Picato properties
June 14, 2013Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA
Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …
LEO Pharma appoints two divisional directors
March 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma
LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …
LEO Pharma appoints new executive vice president
February 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain
From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
